Challenges in drug target discovery in bipolar disorder

Bibliography

• Smith DJ, Griffiths E, Kelly M, Unrecognised bipolar disorder in primary care patients with depression. Br J Psychiatry 2011;199(1):49-56
   PubMed Web of Science ®Google Scholar
• Harris EC, Barraclough B. Excess mortality of mental disorder. Br J Psychiatry 1998;173(1):11-53
   PubMed Web of Science ®Google Scholar
• Michalak EE, Yatham LN, Lam RW. Quality of life in bipolar disorder: a review of the literature. Health Qual Life Outcomes 2005;3:72
   PubMedGoogle Scholar
• Thompson JM, Gallagher P, Hughes JH, Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry 2005;186:32-40
   PubMed Web of Science ®Google Scholar
• Angst J, Sellaro R, Stassen HH, Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions. J Affect Disord 2005;84(2–3):149-57
   PubMed Web of Science ®Google Scholar
• Smith LA, Cornelius V, Warnock A, Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Bipolar Disord 2007;9(4):394-412
   PubMed Web of Science ®Google Scholar
• Bowden CL, Brugger AM, Swann AC, Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994;271(12):918-24
   PubMed Web of Science ®Google Scholar
• Seifuddin F, Mahon PB, Judy J, Meta-analysis of genetic association studies on bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2012;159B(5):508-18
   PubMed Web of Science ®Google Scholar
• Sklar P, Ripke S, Scott LJ, Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011;43(10):977-83
   PubMed Web of Science ®Google Scholar
• D'Addario C, Dell'Osso B, Palazzo MC, Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII. Neuropsychopharmacology 2012;37(7):1647-55
   PubMed Web of Science ®Google Scholar
• Miller S, Hallmayer J, Wang PW, Brain-derived neurotrophic factor val66met genotype and early life stress effects upon bipolar course. J Psychiatr Res 2013;47(2):252-8
   PubMed Web of Science ®Google Scholar
• Machado-Vieira R, Ibrahim L, Zarate CAJ. Histone deacetylases and mood disorders: epigenetic programming in gene-environment interactions. CNS Neurosci Ther 2011;17(6):699-704
   PubMed Web of Science ®Google Scholar
• Sleiman SF, Basso M, Mahishi L, Putting the 'HAT' back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions. Expert Opin Investig Drugs 2009;18(5):573-84
   PubMed Web of Science ®Google Scholar
• Reyes A, Semenkovich NP, Whiteson K, Going viral: next-generation sequencing applied to phage populations in the human gut. Nat Rev Microbiol 2012;10(9):607-17
   PubMed Web of Science ®Google Scholar
• Ross J. Control of messenger RNA stability in higher eukaryotes. Trends Genet 1996;12(5):171-5
   PubMed Web of Science ®Google Scholar
• Wilkins MR, Pasquali C, Appel RD, From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis. Biotechnology 1996;14(1):61–65
   PubMed Web of Science ®Google Scholar
• Huttenhain R, Malmstrom J, Picotti P, Perspectives of targeted mass spectrometry for protein biomarker verification. Curr Opin Chem Biol 2009;13(5–6):518-25
   PubMed Web of Science ®Google Scholar
• Walter G, Bussow K, Lueking A, High-throughput protein arrays: prospects for molecular diagnostics. Trends Mol Med 2002;8(6):250-3
   PubMed Web of Science ®Google Scholar
• Sklar LA, Carter MB, Edwards BS. Flow cytometry for drug discovery, receptor pharmacology and high-throughput screening. Curr Opin Pharmacol 2007;7(5):527–34
   PubMed Web of Science ®Google Scholar
• Elshal MF, McCoy JP. Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods (San Diego, Calif.) 2006;38(4):317-23
   PubMed Web of Science ®Google Scholar
• Caldwell RL, Caprioli RM. Tissue profiling by mass spectrometry: a review of methodology and applications. Mol Cell Proteomics 2005;4(4):394-401
   PubMed Web of Science ®Google Scholar
• Weckwerth W, Fiehn O. Can we discover novel pathways using metabolomic analysis? Curr Opin Biotechnol 2002;13(2):156-60
   PubMed Web of Science ®Google Scholar
• Stein SE. An integrated method for spectrum extraction and compound identification from gas chromatography/mass spectrometry data. J Am Soc Mass Spectrom 1999;305(99):770-81
   Google Scholar
• Ghosh S, Sengupta A, Sharma S, Metabolic fingerprints of serum, brain, and liver are distinct for mice with cerebral and noncerebral malaria: a (1)h NMR spectroscopy-based metabonomic study. J Proteome Res 2012;11(10):4992-5004
   PubMed Web of Science ®Google Scholar
• Szyperski T. 13C-NMR, MS and metabolic flux balancing in biotechnology research. Q Rev Biophys 1998;31:41-106
   PubMed Web of Science ®Google Scholar
• Want EJ, Maille GO, Smith CA, Clustering, and protein extraction for serum profiling with mass spectrometry. Anal Chem 2006;78(3):743-52
   PubMed Web of Science ®Google Scholar
• Krull IS, Swatz M. Analytical method development and validation for the academic researcher. Anal Lett 1999;32(6):1067-80
   Web of Science ®Google Scholar
• Wishart DS, Tzur D, Knox C, HMDB: the human metabolome database. Nucleic Acids Res 2007;35(Database issue):D521-6
   PubMed Web of Science ®Google Scholar
• Mandal R, Guo AC, Chaudhary KK, Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update. Genome Med 2012;4(4):38
   PubMed Web of Science ®Google Scholar
• Berk M, Munib A, Dean O, Qualitative methods in early-phase drug trials: broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophrenia. J Clin Psychiatry 2011;72(7):909-13
   PubMed Web of Science ®Google Scholar
• Kapczinski F, Frey BN, Kauer-Sant'Anna M, Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Rev Neurother 2008;8(7):1101-13
   PubMedGoogle Scholar
• Cunha AB, Andreazza AC, Gomes FA, Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2008;258(5):300-4
   PubMed Web of Science ®Google Scholar
• Brietzke E, Stertz L, Fernandes BS, Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J affect disorders 2009;116(3):214-17
   PubMed Web of Science ®Google Scholar
• Dickerson F, Stallings C, Origoni A, Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder. Prog Neuro Psychopharmacol Biol Psychiatry 2007;31(4):952-5
   PubMed Web of Science ®Google Scholar
• Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009;65(9):732-41
   PubMed Web of Science ®Google Scholar
• Lin M, Pedrosa E, Shah A, RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders. PLoS ONE 2011;6(9):e23356
   PubMed Web of Science ®Google Scholar
• Tordjman S, Drapier D, Bonnot O, Animal models relevant to schizophrenia and autism: validity and limitations. Behav Genet 2007;37(1):61-78
   PubMed Web of Science ®Google Scholar
• Manalai P, Hamilton RG, Langenberg P, Pollen-specific immunoglobulin E positivity is associated with worsening of depression scores in bipolar disorder patients during high pollen season. Bipolar Disord 2012;14(1):90-8
   PubMed Web of Science ®Google Scholar
• Penninx BWJH, Beekman ATF, Smit JH, The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res 2008;17(3):121-40
   PubMed Web of Science ®Google Scholar
• Bouaziz M, Ambroise C, Guedj M. Accounting for population stratification in practice: a comparison of the main strategies dedicated to genome-wide association studies. PLoS ONE 2011;6(12):e28845
   PubMed Web of Science ®Google Scholar
• Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003;361(9357):598-604
   PubMed Web of Science ®Google Scholar
• Frye MA, Altshuler LL, McElroy SL, Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. Am J Psychiatry 2003;160(5):883-9
   PubMed Web of Science ®Google Scholar
• Lacro JP, Dunn LB, Dolder, Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002;63(10):892-909
   PubMed Web of Science ®Google Scholar
• Marcus SM, Young EA, Kerber KB, Gender differences in depression: findings from the STAR*D study. J Affect Disord 2005;87(2–3):141-50
   PubMed Web of Science ®Google Scholar
• Herberth M, Koethe D, Levin Y, Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival. Proteomics 2011;11(1):94-105
   PubMed Web of Science ®Google Scholar
• Bardenstein KK, McGlashan TH. Gender differences in affective, schizoaffective, and schizophrenic disorders. A review. Schizophr Res 1990;3(3):159-72
   PubMed Web of Science ®Google Scholar
• Soreca I, Fagiolini A, Frank E, Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder. J Psychiatr Res 2008;42(11):956-61
   PubMed Web of Science ®Google Scholar
• Rowe MK, Wiest C, Chuang D-M. GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder. Neurosci Biobehav Rev 2007;31(6):920-31
   PubMed Web of Science ®Google Scholar
• Bijur GN, Jope RS. Glycogen synthase kinase-3β is highly activated in nuclei and mitochondria. Neuroreport 2003;14(18):2415-19
   PubMed Web of Science ®Google Scholar
• Hoshi M, Takashima A, Noguchi K, Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3β in brain. Proc Natl Acad Sci USA 1996. 93(7): 2719-23
   Google Scholar
• Bertolino A, Frye M, Callicott JH, Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry 2003;53(10):906-13
   PubMed Web of Science ®Google Scholar
• Winsberg ME, Sachs N, Tate DL, Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry 2000;47(6):475-81
   PubMed Web of Science ®Google Scholar
• Andreazza AC, Shao L, Wang J-F, Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry 2010;67(4):360-8
   PubMed Web of Science ®Google Scholar
• Quiroz JA, Gray NA, Kato T, Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 2008;33(11):2551-65
   PubMed Web of Science ®Google Scholar
• Linseman DA, Butts BD, Precht TA, Glycogen synthase kinase-3β phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J Neurosci 2004;24(44):9993-10002
   PubMed Web of Science ®Google Scholar
• Juhaszova M, Zorov DB, Kim S-H, Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 2004;113(11):1535-49
   PubMed Web of Science ®Google Scholar
• Bachmann RF, Schloesser RJ, Gould TD, Mood stabilizers target cellular plasticity and resilience cascades implications for the development of novel therapeutics. Mol Neurobiol 2005;32(2):173-202
   PubMed Web of Science ®Google Scholar
• Gould TD, Einat H, Bhat R, AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int J Neuropsychopharmacol 2004;7(4):387-90
   PubMed Web of Science ®Google Scholar
• McNamara RK, Ostrander M, Abplanalp W, Modulation of phosphoinositide-protein kinase C signal transduction by omega-3 fatty acids: implications for the pathophysiology and treatment of recurrent neuropsychiatric illness. Prostaglandins Leukot Essent Fatty Acids 2006;75(4–5):237-57
   PubMed Web of Science ®Google Scholar
• Kato T, Takahashi S, Shioiri T, Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy. J Affect Disord 1993;27(1):53-9
   PubMed Web of Science ®Google Scholar
• Kato T, Shioiri T, Takahashi S, Measurement of brain phosphoinositide metabolism in bipolar patients using in vivo 31P-MRS. J Affect Disord 1991;22(4):185-90
   PubMed Web of Science ®Google Scholar
• Manji HK, Bersudsky Y, Chen G, Modulation of protein kinase C isozymes and substrates by lithium: the role of myoinositol. Neuropsychopharmacology 1996;15(4):370-81
   PubMed Web of Science ®Google Scholar
• Preece NE, Gadian DG, Houseman J, Lithium-induced modulation of cerebral inositol phosphate metabolism in the rat: a multinuclear magnetic resonance study in vivo. Rec Display 1992;3(4):287-97
   Google Scholar
• Lan MJ, McLoughlin GA, Griffin JL, Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Mol Psychiatry 2008;14(3):269-79
   PubMed Web of Science ®Google Scholar
• Stork C, Renshaw PF. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry 2005;10(10):900-19
   PubMed Web of Science ®Google Scholar
• Kim H, McGrath BM, Silverstone PH. A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders–focus on magnetic resonance spectroscopy (MRS) studies. Hum Psychopharmacol 2005;20(5):309-26
   PubMed Web of Science ®Google Scholar
• Friedman E, Hoau Yan W, Levinson D, Altered platelet protein kinase C activity in bipolar affective disorder, manic episode. Biol Psychiatry 1993;33(7):520-5
   PubMed Web of Science ®Google Scholar
• Pandey GN, Dwivedi Y, SridharaRao J, Protein kinase C and phospholipase C activity and expression of their specific isozymes is decreased and expression of MARCKS is increased in platelets of bipolar but not in unipolar patients. Neuropsychopharmacology 2002;26(2):216-28
   PubMed Web of Science ®Google Scholar
• de Oliveira GS, Cereser KM, Fernandes BS, Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. J Psychiatr Res 2009;43(14):1171-4
   PubMed Web of Science ®Google Scholar
• Cunha ABM, Frey BN, Andreazza AC, Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett 2006;398(3):215-19
   PubMed Web of Science ®Google Scholar
• Tramontina JF, Andreazza AC, Kauer-Sant'anna M, Brain-derived neurotrophic factor serum levels before and after treatment for acute mania. Neurosci Lett 2009;452(2):111-13
   PubMed Web of Science ®Google Scholar
• Maes M, Delange J, Ranjan R, Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res 1997;66(1):1-11
   PubMed Web of Science ®Google Scholar
• Shaltiel G, Chen G, Manji HK. Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder. Curr Opin Pharmacol 2007;7(1):22-6
   PubMed Web of Science ®Google Scholar
• Balanza-Martinez V, Fries GR, Colpo GD, Therapeutic use of omega-3 fatty acids in bipolar disorder. Expert Rev Neurother 2011;11(7):1029-47
   PubMed Web of Science ®Google Scholar
• Kurdistani SK, Tavazoie S, Grunstein M. Mapping global histone acetylation patterns to gene expression. Cell 2004;117(6):721-33
   PubMed Web of Science ®Google Scholar
• Phiel CJ, Zhang F, Huang EY, Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001;276(39):36734-41
   PubMed Web of Science ®Google Scholar
• Tsankova N, Renthal W, Kumar A, Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 2007;8(5):355-67
   PubMed Web of Science ®Google Scholar
• Sharma RP, Rosen C, Kartan S, Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population. Schizophr Res 2006;88(1–3):227-31
   PubMed Web of Science ®Google Scholar
• Strahl BD, Allis CD. The language of covalent histone modifications. Nature 2000;403(6765):41-5
   PubMed Web of Science ®Google Scholar
• Welches WR, Brosnihan KB, Ferrario CM. Minireview: a comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci 1993;52:1461-80
   PubMed Web of Science ®Google Scholar
• Ebstein RP, Knafo A, Mankuta D, The contributions of oxytocin and vasopressin pathway genes to human behavior. Horm Behav 2012;61(3):359-79
   PubMed Web of Science ®Google Scholar
• Maes M, Goossens F, Scharpe S, Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs. Psychiatry Res 1995;58(3):217-25
   PubMed Web of Science ®Google Scholar
• Williams RSB, Cheng L, Mudge AW, A common mechanism of action for three mood-stabilizing drugs. Nature 2002;417(6886):292-5
   PubMed Web of Science ®Google Scholar
• Schulz I, Gerhartz B, Neubauer A, Modulation of inositol 1,4,5-triphosphate concentration by prolyl endopeptidase inhibition. Eur J Biochem 2002;269(23):5813-20
   PubMedGoogle Scholar
• Cheng L, Lumb M, Polgar L, How can the mood stabilizer VPA limit both mania and depression? Mol Cell Neurosci 2005;29(2):155-61
   PubMed Web of Science ®Google Scholar
• Maes M, Lin AH, Bonaccorso S, Higher serum prolyl endopeptidase activity in patients with post-traumatic stress disorder. J Affect Disord 1999;53(1):27-34
   PubMed Web of Science ®Google Scholar
• Maes M, Scharpe S, De Meester I, Components of biological variation in prolyl endopeptidase and dipeptidyl-peptidase IV activity in plasma of healthy subjects. Clin Chem 1994;40(9):1686-91
   PubMed Web of Science ®Google Scholar
• Pirke KM, Broocks A, Wilckens T, Starvation-induced hyperactivity in the rat: the role of endocrine and neurotransmitter changes. Neurosci Biobehav Rev 1993;17(3):287-94
   PubMed Web of Science ®Google Scholar
• Chalmers S, Nicholls DG. The relationship between free and total calcium concentrations in the matrix of liver and brain mitochondria. J Biol Chem 2003;278(21):19062-70
   PubMed Web of Science ®Google Scholar
• Chen G, Zeng WZ, Yuan PX, The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 1999;72(2):879-82
   PubMed Web of Science ®Google Scholar
• Bown CD, Wang JF, Young LT. Increased expression of endoplasmic reticulum stress proteins following chronic valproate treatment of rat C6 glioma cells. Neuropharmacology 2000;39(11):2162-9
   PubMed Web of Science ®Google Scholar
• Chen B, Wang JF, Young LT. Chronic valproate treatment increases expression of endoplasmic reticulum stress proteins in the rat cerebral cortex and hippocampus. Biol Psychiatry 2000;48(7):658-64
   PubMed Web of Science ®Google Scholar
• Shao L, Sun X, Xu L, Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells. Life Sci 2006;78(12):1317-23
   PubMed Web of Science ®Google Scholar
• Liu H. Endoplasmic reticulum chaperones GRP78 and calreticulin prevent oxidative stress, Ca2+ disturbances, and cell death in renal epithelial cells. J Biol Chem 1997;272(35):21751-9
   PubMed Web of Science ®Google Scholar
• Casamassima F, Hay AC, Benedetti A, L-type calcium channels and psychiatric disorders: a brief review. Am J Med Genet B Neuropsychiatr Genet 2010;153B(8):1373-90
   PubMed Web of Science ®Google Scholar
• Silverstone PH, Birkett L. Diltiazem as augmentation therapy in patients with treatment-resistant bipolar disorder: a retrospective study. J Psychiatry Neurosci 2000;25(3):276-80
   PubMed Web of Science ®Google Scholar
• Bown CD, Wang J-F, Chen B, Regulation of ER stress proteins by valproate: therapeutic implications. Bipolar Disord 2002;4(2):145-51
   PubMed Web of Science ®Google Scholar
• Kato T, Takahashi S, Shioiri T, Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord 1994;31(2):125-33
   PubMed Web of Science ®Google Scholar
• Kato T, Takahashi S, Shioiri T, Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord 1992;26(4):223-30
   PubMed Web of Science ®Google Scholar
• Hamakawa H, Murashita J, Yamada N, Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder. Psychiatry Clin Neurosci 2004;58(1):82-8
   PubMed Web of Science ®Google Scholar
• Dager SR, Friedman SD, Parow A, Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 2004;61(5):450-8
   PubMed Web of Science ®Google Scholar
• Buchsbaum MS, Wu J, DeLisi LE, Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J affect Disord 1986;10(2):137-52
   PubMed Web of Science ®Google Scholar
• Menke A, Lucae S, Kloiber S, Genetic markers within glutamate receptors associated with antidepressant treatment-emergent suicidal ideation. Am J Psychiatry 2008;165(7):917-18
   PubMed Web of Science ®Google Scholar
• Kato T, Shioiri T, Murashita J, Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS. Psychol Med 1995;25(3):557-66
   PubMed Web of Science ®Google Scholar
• Bahtiyar G, Weiss K, Sacerdote AS. Novel endocrine disrupter effects of classic and atypical antipsychotic agents and divalproex: induction of adrenal hyperandrogenism, reversible with metformin or rosiglitazone. Endocr Pract 2007;13(6):601-8
   PubMedGoogle Scholar
• Landreth G, Jiang Q, Mandrekar S, PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease. Neurotherapeutics 2008;5(3):481-9
   PubMed Web of Science ®Google Scholar
• Brietzke E, Kapczinski F, Grassi-Oliveira R, Insulin dysfunction and allostatic load in bipolar disorder. Expert Rev Neurother 2011;11(7):1017-28
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Soczynska JK, Woldeyohannes HO, A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder. Bipolar Disord 2012;14(7):697-706
   PubMed Web of Science ®Google Scholar
• Schondorf T, Karagiannis E, Posseldt REK, Competact, a fixed combination of pioglitazone and metformin, improves metabolic markers in type 2 diabetes patients with insufficient glycemic control by metformin alone–results from a post-marketing surveillance trial under daily routine conditions. Diabetes Technol Ther 2009;11(6):379-83
   PubMed Web of Science ®Google Scholar
• Ben-Shachar D, Bonne O, Chisin R, Cerebral glucose utilization and platelet mitochondrial complex I activity in schizophrenia: A FDG-PET study. Prog Neuro Psychopharmacol Biol Psychiatry 2007;31(4):807-13
   PubMed Web of Science ®Google Scholar
• O'Loughlin A, Lynn DJ, McGee M, Transcriptomic analysis of the stress response to weaning at housing in bovine leukocytes using RNA-seq technology. BMC Genomics 2012;13(1):250
   PubMedGoogle Scholar
• Bandura DR, Baranov VI, Ornatsky OI, Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. Anal Chem 2009;81(16):6813-22
   PubMed Web of Science ®Google Scholar
• Bodenmiller B, Zunder ER, Finck R, Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators. Nat Biotechnol 2012;30(9):857-66
   Web of Science ®Google Scholar
• Bendall SC, Nolan GP. From single cells to deep phenotypes in cancer. Nat Biotechnol 2012;30(7):639-47
   PubMed Web of Science ®Google Scholar
• Brennand KJ, Simone A, Jou J, Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011;473(7346):221-5
   PubMed Web of Science ®Google Scholar
• Guest PC, Schwarz E, Krishnamurthy D, Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia. Psychoneuroendocrinology 2011;36(7):1092-6
   PubMed Web of Science ®Google Scholar
• Izmailov R, Guest PC, Bahn S, Algorithm development for diagnostic biomarker assays. Int Rev Beurobiol 2011;101:279-98
   PubMed Web of Science ®Google Scholar
• Schwarz E, Izmailov R, Spain M, Biomarker insights validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia. Biomark Insights 2010;12:39-47
   Google Scholar
• Iris F. Psychiatric systems medicine: closer at hand than anticipated but not with the expected portrait. Pharmacopsychiatry 2012;45(Suppl 1):12-21
   Google Scholar
• Alawieh A, Zaraket FA, Li JL, Systems biology, bioinformatics, and biomarkers in neuropsychiatry. Front Neurosci 2012;6:1-16
   PubMed Web of Science ®Google Scholar
• Marin-Sanguino A, Mendoza ER. Hybrid modeling in computational neuropsychiatry. Pharmacopsychiatry 2008;41:85-8
   Web of Science ®Google Scholar
• Tretter F, Gebicke-Haerter PJ, an der Heiden U, Affective disorders as complex dynamic diseases - a perspective from systems biology. Pharmacopsychiatry2011;44:2-8
   Web of Science ®Google Scholar